Cite
HARVARD Citation
Vitale, M. et al. (2021). Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma. Expert review of anticancer therapy. 21 (11), pp. 1183-1192. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vitale, M. et al. (2021). Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma. Expert review of anticancer therapy. 21 (11), pp. 1183-1192. [Online].